Alliancebernstein L.P. Biomarin Pharmaceutical Inc Transaction History

Alliancebernstein L.P.

  • $290 Billion
  • Q2 2025

A detailed history of Alliancebernstein L.P. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 273,505 shares of BMRN stock, worth $15.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
273,505
Previous 318,979 14.26%
Holding current value
$15.2 Million
Previous $22.5 Million 33.32%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
$54.08 - $68.32 $2.46 Million - $3.11 Million
-45,474 Reduced 14.26%
273,505 $15 Million
Q1 2025

May 15, 2025
BUY
$61.25 - $72.83 $3.77 Million - $4.49 Million
61,594 Added 23.93%
318,979 $22.5 Million
Q4 2024

Feb 12, 2025
SELL
$61.93 - $70.49 $1.37 Million - $1.55 Million
-22,055 Reduced 7.89%
257,385 $16.9 Million
Q3 2024

Nov 14, 2024
SELL
$69.02 - $93.84 $1.05 Million - $1.43 Million
-15,204 Reduced 5.16%
279,440 $19.6 Million
Q2 2024

Aug 14, 2024
BUY
$74.43 - $92.22 $15.1 Million - $18.7 Million
203,137 Added 221.99%
294,644 $24.3 Million
Q1 2024

May 14, 2024
BUY
$83.81 - $99.0 $85,821 - $101,376
1,024 Added 1.13%
91,507 $7.99 Million
Q4 2023

Feb 14, 2024
BUY
$76.22 - $98.51 $134,299 - $173,574
1,762 Added 1.99%
90,483 $8.72 Million
Q3 2023

Nov 14, 2023
SELL
$85.07 - $94.48 $5.5 Million - $6.1 Million
-64,613 Reduced 42.14%
88,721 $7.85 Million
Q2 2023

Aug 15, 2023
SELL
$86.68 - $100.3 $2.02 Million - $2.34 Million
-23,357 Reduced 13.22%
153,334 $13.3 Million
Q1 2023

May 15, 2023
BUY
$87.74 - $117.27 $7.79 Million - $10.4 Million
88,833 Added 101.11%
176,691 $17.2 Million
Q4 2022

Feb 14, 2023
SELL
$80.93 - $108.63 $348,727 - $468,086
-4,309 Reduced 4.68%
87,858 $9.09 Million
Q3 2022

Nov 15, 2022
SELL
$82.16 - $96.94 $11.3 Million - $13.3 Million
-137,670 Reduced 59.9%
92,167 $7.81 Million
Q2 2022

Aug 15, 2022
BUY
$71.48 - $86.85 $3.47 Million - $4.21 Million
48,476 Added 26.73%
229,837 $19 Million
Q1 2022

May 13, 2022
SELL
$74.28 - $92.69 $14.2 Million - $17.8 Million
-191,716 Reduced 51.39%
181,361 $14 Million
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $2.51 Million - $3.21 Million
35,043 Added 10.37%
373,077 $33 Million
Q3 2021

Nov 10, 2021
BUY
$74.77 - $85.47 $13.8 Million - $15.8 Million
184,974 Added 120.85%
338,034 $26.1 Million
Q2 2021

Jul 30, 2021
BUY
$75.51 - $84.79 $3.49 Million - $3.92 Million
46,174 Added 43.2%
153,060 $12.8 Million
Q1 2021

May 06, 2021
SELL
$74.73 - $90.69 $23.3 Million - $28.2 Million
-311,202 Reduced 74.43%
106,886 $8.07 Million
Q4 2020

Feb 08, 2021
BUY
$72.61 - $90.2 $8.51 Million - $10.6 Million
117,161 Added 38.93%
418,088 $36.7 Million
Q3 2020

Nov 12, 2020
BUY
$71.87 - $131.03 $3.55 Million - $6.47 Million
49,403 Added 19.64%
300,927 $22.9 Million
Q2 2020

Aug 13, 2020
BUY
$79.55 - $124.22 $11.9 Million - $18.6 Million
150,092 Added 147.97%
251,524 $31 Million
Q1 2020

May 14, 2020
SELL
$71.37 - $96.85 $448,917 - $609,186
-6,290 Reduced 5.84%
101,432 $8.57 Million
Q4 2019

Feb 18, 2020
BUY
$64.27 - $86.37 $120,441 - $161,857
1,874 Added 1.77%
107,722 $9.11 Million
Q3 2019

Nov 14, 2019
SELL
$67.4 - $85.11 $75,555 - $95,408
-1,121 Reduced 1.05%
105,848 $7.13 Million
Q2 2019

Aug 14, 2019
BUY
$80.35 - $93.9 $82,921 - $96,904
1,032 Added 0.97%
106,969 $9.16 Million
Q1 2019

May 14, 2019
SELL
$84.2 - $98.62 $68,454 - $80,178
-813 Reduced 0.76%
105,937 $9.41 Million
Q4 2018

Feb 13, 2019
SELL
$80.14 - $106.07 $166,050 - $219,777
-2,072 Reduced 1.9%
106,750 $9.09 Million
Q3 2018

Nov 08, 2018
BUY
$93.92 - $105.72 $42,639 - $47,996
454 Added 0.42%
108,822 $10.6 Million
Q2 2018

Aug 13, 2018
SELL
$76.01 - $99.03 $6.75 Million - $8.8 Million
-88,832 Reduced 45.05%
108,368 $10.2 Million
Q1 2018

May 14, 2018
BUY
$77.67 - $92.63 $3.79 Million - $4.52 Million
48,820 Added 32.9%
197,200 $16 Million
Q4 2017

Feb 13, 2018
BUY
$80.76 - $95.13 $2.53 Million - $2.98 Million
31,320 Added 26.76%
148,380 $13.2 Million
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $9.44 Million - $11.1 Million
117,060
117,060 $10.9 Million

Others Institutions Holding BMRN

# of Institutions
675
Shares Held
185M
Call Options Held
1.31M
Put Options Held
1.1M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $10.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email